KLF2 and atherosclerosis: S-flow activates KLF2 and KLF4, transcription factors critical for suppressing atherosclerosis by modulating endothelial nitric oxide synthase (eNOS)-associated pathways, including cGMP-PKG, cAMP, and insulin signaling.